Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1/2, p38α, and NF-κB signaling
Rania M. Khalil, Ahmed Shata, Eman M. Abd El-Kader, Hossam Sharaf, Walied Abdo, Noha A. Amin, Sameh Saber
Topics & Concepts
HepatoprotectionPharmacologyPhosphorylationCCL4MAPK/ERK pathwaySignal transductionp38 mitogen-activated protein kinasesKinaseProtein kinase AChemistryCancer researchCell biologyBiologyBiochemistryCarbon tetrachlorideGlutathioneOrganic chemistryEnzymeLiver physiology and pathologyDrug Transport and Resistance MechanismsDrug-Induced Hepatotoxicity and Protection